FDA clears Integra's advanced ICP (intracranial pressure) catheter:
This article was originally published in Clinica
Integra LifeSciences has received US FDA 510(k) marketing clearance for its advanced intracranial pressure (ICP) monitoring and drainage catheter. The fibre optic-based Ventrix true tech catheter is designed to tunnel away from the brain, a technique used previously only in fluid-filled ICP monitoring systems, says the Plainsboro, New Jersey company. The new product eliminates the levelling and de-bubbling associated with the fluid-filled systems, says Integra, which launched the device last week.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.